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Assessment of an osteoblastlike cell line as a model for human primary
osteoblasts using Raman spectroscopy
Lindsay. L. McManus1* , Franck. Bonnier2, George. A. Burke1 , Brian. J. Meenan1,
Adrian. R. Boyd1 and Hugh. J. Byrne2
1. Engineering Research Institute, Nanotechnology and Integrated BioEngineering Centre
(NIBEC), University of Ulster, BT37 0QB, Northern Ireland
2. Focas Research Institute, Dublin Institute of Technology (DIT), Kevin Street,
Dublin 8, Ireland
Abstract
Raman spectroscopy is employed to determine the suitability of the U20S osteoblastlike cell
line for use as a model for human primary osteoblasts, with emphasis on the ability of these cell
types to replicate their tissue of origin. It was found that both cell types demonstrated early stage
mineral deposition that followed significantly different growth patterns. Analysis of the growth
pattern and spectral data from primary cells revealed increasing bone quality ratios and a high
crystallinity, consistent with previous reports.

Conversely the investigation of the U20S

osteoblastlike cell line provided evidence of dense multilayered mineralised regions that
corresponded more closely to native bone in terms of its crystallinity and bone quality ratios.
This finding contradicts previous reports on U20S osteoblastlike cells which have consistently
described them as nonosteoinductive when cultured in various conditions on a number of
substrates. This work demonstrates the successful application of Raman spectroscopy combined
with biological and multivariate analysis for the investigation of osteoblastlike U20S cells and
human primary osteoblasts, specifically with focus on the osteoinductive ability of the
osteoblastlike cell line and the comparative differences in relation to the primary osteoblasts.

* Corresponding author. Tel.: +44 (0) 2890 368928, Fax: +44 (0) 2890 366863

Email address: linzimcmanus@gmail.com (L. McManus)

Introduction
When investigating diseases such as cancer, one point of focus is on the identification of drugs
that have a positive influence on metabolic uptake, cell differentiation and the induction of cell
death. Stem cells are now commonly being used in regenerative medicine and tissue engineering
applications with the primary aim of replacing or repairing tissue that has been diseased or
damaged [1]. The fulfilment of this aim relies heavily on understanding cell behaviour and cell
interaction with other tissues and materials both in vitro and in vivo. From this perspective,
primary cells and lineagespecific cells are the gold standard when studying live cell interactions
in vitro. With particular relevance to bone tissue engineering, de novo bone can be produced by
culturing bone cells onto different biomaterials.

Osteoblasts initiate bone formation by

producing osteoid prior to the mineralisation process. Osteoid is an unmineralised intracellular
matrix composed of collagen fibrils and fibres combined with a proteinaceous component that
mineralises to become bone. As a result, osteoblasts are essential for the process of bone
remodelling and play a crucial role in healing various bone diseases [26]. Primary cells are
traditionally used when studying live cell interactions and, in this respect, primary osteoblast
cells isolated directly from the patient are the ideal model when investigating the formation of
new bone. However, their use is restricted due to the difficulty faced when isolating bone
fragments that are capable of producing cells that can be harvested in sufficient numbers.
Primary osteoblasts are also challenging to expand in vitro and with increasing passage number
they can lose their phenotype in a process known as dedifferentiation, leading to a finite life
span [79]. More recently, Rubio et al. have reported the spontaneous transformation of adult
stem cells with increasing passage number, therefore indicating the safety concerns when
expanding cells in large numbers [10].
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To overcome these limitations, cell lines are often used as an alternative model for primary cells
and, to date, many cell line models have been chosen because they have a longer lifespan than
primary cells. They can also proliferate indefinitely, whilst maintaining phenotypic stability,
therefore overcoming the limitations of using primary cells. These cell lines are routinely used
to provide an understanding that reflects the interaction of osteoblasts with various materials [11
14], and are typically obtained by the immortalization of primary cells through transduction or
retroviral transfection or, in the current study, from cancerous osteosarcoma tissue. However,
the use of osteoblastlike cell lines presents a major potential drawback, which is that the
phenotype expressed may not be a true representation of the phenotype of primary osteoblasts
[15, 16].

Human osteoblastlike cell lines have been used in bone tissue engineering as models for
investigating primary osteoblast function and they are used regularly to study growth, integral
expression, cell function and the effects of cytokines and growth factors. Bilbe et al. reported
that three osteoblastlike cell lines were highly comparable with primary osteoblasts. This
finding was based on the similar expressions of a total of 58 cytokines, growth factors and bone
related proteins from the cell lines and primary cells [15]. Conversely, Clover et al. found that,
depending on the osteoblastic function being investigated, osteoblastlike cell lines could be used
as appropriate models of primary cells. Osteoblastlike cell lines were concluded to be ideal
models for investigating integrin expression, cell adhesion and the production of osteocalcin.
However, in terms of alkaline phosphatase expression and cell proliferation, osteoblastlike cells
were not a good representation of primary cells [16].
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Various studies have reported the use of osteoblastlike cells derived from osteosarcoma and
have established the relevance of their use to study in vitro interactions with biomaterials [17
19], bone cell mineralisation [20, 21], and regarding their suitability for a stable representation of
their primary counterparts [7].

Using Raman spectroscopy, similarities in phenotype and

biochemical composition have been found, as well as many differences between primary cells
and the various sarcoma derived cell lines, including the decrease in the concentration of nucleic
acids in sarcoma derived cells and the increase in protein concentrations in primary cells [7].

Various biological, univariate and multivariate techniques have been employed in parallel with
Raman spectroscopy to provide a comprehensive comparison of the osteoinductive potential of
human primary osteoblasts (HOBs) and osteoblastlike U20S cells (U20Ss).

This paper

determines the suitability of the U20S osteoblastlike cell line as an alternative to primary
osteoblast cells. It presents spectral data from primary cells which indicate increasing bone
quality ratios and a high crystallinity with culture time. Similarly, there is evidence of a bone
material produced by U20Ss that is comparable to native bone with respect to its crystallinity and
bone quality markers. This in itself is a very interesting finding, Due to the apparent non
osteoinductive ability of this cell type [2224].

Materials and methods
Primary cell culture
Primary HOBs derived from cancellous bone pieces (Promocell, UK) were used in this study.
Isolation is performed by the manufacturer. Briefly, cancellous bone was cut into small pieces
that are approximately 24 mm in width with appropriate bone scissors. The pieces were washed
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and cultivated on a plastic flask with the manufacturers osteoblast growth medium. After 13
weeks, the osteoblasts grow out of the bone pieces and proliferate. Cells were maintained in
osteoblast basal media (product number C27001B) and supplemented with osteoblast
supplement mix (product number C39616) which includes ascorbic acid and foetal bovine
serum.

Osteogenic differentiation was induced by culturing HOBs in osteoblast mineralisation medium
(product number C27020), supplemented with osteogenic differentiation medium supplement
mix (product number C39616) which contains ascorbic acid, betaglycerophosphate,
dexamethasone and foetal bovine serum. All cells were maintained below 70% confluency and
were passaged every three to four days using 0.05% trypsinEDTA.

All chemicals were

purchased from Promocell, UK. HOBs were seeded at a density of approximately 30,000 cells
per cm2 onto calcium fluoride (CaF2) substrates (Crystran, UK). Cells were cultured in normal
humidified conditions at 37 ºC, 5% CO2 for 7, 14, 21 and 28 days, respectively.

Osteoblastlike cell culture
U20S osteoblastlike cells cultivated from the bone tissue of a 15 year old female suffering from
a moderately differentiated osteosarcoma of the tibia were used in this study (Health Protection
Agency, UK).

Cells were maintained in McCoy’s 5A medium and supplemented with L

Glutamine and 10% foetal bovine serum (Invitrogen, UK).

Mineralisation was induced by culturing U20Ss in osteoblast media supplemented with 10 nM
dexamethasone, 10 mM betaglycerophosphate and 0.05 mM ascorbic acid2phosphate
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(Invitrogen, UK). All cells were maintained at below 70% confluency and were passaged every
three to four days using 0.25% trypsinEDTA (Sigma, UK). U20Ss were seeded at a density of
10,000 cells per cm2 onto CaF2 substrates (Crystran, UK).

Cells were cultured in normal

humidified conditions at 37 ºC, 5% CO2 for 7, 14, 21 and 28 days, respectively.

For Raman analysis, all samples were taken at seven day intervals and fixed in 10% formalin
solution for 10 mins, cells were then stored in 0.9% sodium chloride (NaCl) for up to 3 weeks.

Alizarin red staining
To confirm the presence of mineralisation, alizarin red staining was performed at days 7, 14, 21
and 28. Cells were washed three times in PBS, fixed and permeabilised in 4% paraformaldehyde
(PFA), with 0.1% Triton X100 for 20 minutes at room temperature then washed twice in de
ionised water to remove residual PFA. Cells were stained with 2% alizarin red for 30 minutes at
room temperature with gentle shaking. For the colorimetric assay 3.6% (0.1M) cetylpyridinium
chloride was added to each sample for 45 minutes and the optical density was measured at 405
nm.

Raman spectroscopy
Raman spectra of nonosteogenic and osteogenic cultured HOBs and U20Ss were obtained at
seven day intervals up to 28 days using A Horiba JobinYvon LabRAM HR800 UV spectrometer
with a single mode diode laser operating at 660 nm. For all spectral measurements, a x100 water
immersion objective (LUMPlanF1, Olympus, N.A. 1.00W) was employed, providing a spatial
resolution of ~1μm at the sample. The confocal hole was set at 100 μm for all measurements
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(the specified setting for confocal operation). The system was spectrally calibrated to the 520.7
cm1 spectral line of Silicon. The LabRAM system is a confocal spectrometer that contains two
interchangeable gratings (300 and 900 lines/mm respectively). In the following experiments the
300 lines/mm grating was employed, which has a spectral dispersion of ~1.5 cm1 per pixel. The
detector used was a 16bit dynamic range Peltier cooled CCD detector. Images of the sample
were acquired using a video camera within the system.

Immunocytochemistry
After 28 days, cells were washed in large volumes of icecold PBS (3 x 5 min), fixed and
permeabilised in 4% PFA containing 0.1% Triton X100 for 20 minutes at 4oC and stained with
bone specific proteins, including, osteocalcin, osteopontin, alkaline phosphatase and SPARC
(osteonectin) (Santa Cruz Biotechnology Inc, USA). Following washing, samples were treated
with a blocking solution (PBS containing 1.0% BSA, 5% normal goat serum (NGS)) for 30
minutes at room temperature.

After blocking, the samples were washed in PBS and then

incubated with the appropriate primary antibodies for 1 hour before exposure to the opposite
secondary antibodies. Following secondary antibody incubation, cells were counterstained with
DAPI nucleic acid stain (Molecular Probes, Inc. Invitrogen). After washing twice in PBS,
substrates were mounted in Vector shield mounting media (Vector Laboratories, UK). The
substrates were sealed using a clear nail varnish and examined using a Carl Zeiss LSM5 Pascal
(Carl Zeiss MicroImaging, Germany) Confocal Laser Scanning Microscope (CLSM).
diluent for all antibodies was PBS  1% BSA.
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The

Data preprocessing
It is accepted that spectral artifacts can have a considerable effect on the interpretation of data.
Therefore it is necessary to distinguish between biochemical information and undesired effects.
With Raman spectroscopy, is it known that before data interpretation can be performed, pre
processing of data should be carried out. To this end, Matlab (Mathworks, USA) was used to
routinely preprocess the raw data. In the first instance, band alignment was performed to
correct for instrumental spectral shifts. As such, all spectra were normalised using the area of the
1449 cm1 band. A CaF2 background spectrum was acquired for each individual substrate used,
and subsequently subtracted before averaging. A simple baseline subtraction was performed and
smoothing by a 5 th order, 11point SavitzkyGolay filter.

Principal Component Analysis
Principal component analysis is a multivariate analysis technique that is widely used to simplify
a complex data set of multiple dimensions. It allows the transformation of different sets of
variables into a smaller set of new variables or principal components that capture the maximum
variance in the data. The order of the principal components represents their importance to the
original dataset, so the greatest variance is illustrated by the first principal component (PC1); the
second greatest variance is the second principal component (PC2) and so forth. In principle,
each principal component is a linear combination of the original variables for the simplified
variables, therefore, var (PC1) ≥ var (PC2) ≥ (PCp), where var (PCi) represents the variance of
PCi in the dataset. A scatter plot is generated from the data which shows groups of points
representing variations within the dataset [25]. PCA was performed using Matlab (Mathworks,
USA) following the different data analysis steps described in the previous section. The other
advantage of this method is the observation of loadings which represent the variance for each
8

variable (wavenumber) for a given PC. Analysing the loadings of a PC can give information
about the source of the variability inside a dataset, derived from variations in the molecular
components contributing to the spectra.

This statistical method of analysis was preferred because it is able to resolve spectral components
that are present in different proportions. This is extremely important when bone is the material
being analysed, as it is heterogeneous in nature, which results in considerable variations in its
spectra.

Results and discussion
Cell morphology
HOBs are widely dispersed cells with a prominent nucleus and they exhibit a typical elongated
fibroblastlike morphology with a spindlelike appearance (Supplementary Figure 1AB). They
have a relatively large body and were measured to be approximately 130160 μm in length and
1020 μm in diameter with an aspect ratio of 8.3 ± 3.6. The morphology of U20Ss differs and as
such the U20Ss used during this study exhibit typical epithelial morphological characteristics.
After 48 h in culture, there was little to no overlap observed and the cells were generally
hexagonal in shape and of a ‘cobblestone’ appearance that are interconnected by cell processes
(Supplementary Figure 1CD). U20S cells have a small cell body with a large cell nucleus and
few cytoplasmic processes and were measured to be approximately 3055 μm in length and 25
50 μm in diameter with an aspect ratio of 1.2 ± 1.1.
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Both nonosteogenic and osteogenic HOBs cell cultures underwent differing growth patterns, as
expected. As can be seen in Fig. 1, for cells grown in nonosteogenic media (Fig. 1A), there was
no evidence of mineral formation.

Nonosteogenic HOBs maintained a fibroblastlike

morphology with a spindlelike shaped cell body throughout the 28 day culture period. Fig. 1A
shows the control of HOBs samples cultured in nonosteogenic media, HOBs cultured in
osteogenic media for 7 days (Fig. 1B) highlights a change in growth pattern. When cultured for
7 days in media with osteogenic supplements, whilst no calcium deposition or mineral formation
is observed, there is a dramatic change in cell morphology. HOBs have not maintained the
elongated fibroblast appearance that is observed in Fig. 1A, instead they have become more
cuboidal in shape and have formed a dense monolayer during the 7 days in culture. At day 14,
HOBs appear more rounded in shape and the monolayer has become thicker. Cell/protein
aggregation within the monolayer is also observed at this culture time point, as shown in Fig. 1C.
Dramatic changes in cell morphology are observed between days 1421. Fig. 1C and Fig. 1D
show that between these culture times, the cell monolayer became patchy and in the outer
regions of the cell monolayer, there are discrete areas of calcium deposition and bone nodule
formation. By day 28, as shown in Fig. 1E the outer region of the cell monolayer shows discrete
areas of calcium deposition. There are no bone nodules observed in Fig. 1E. However, at this
time point there were small nodules present (not shown here).

Significant differences were observed in the growth pattern of U20Ss over the 28 day culture
period of nonosteogenic and osteogenic culture. Fig. 2 shows U20Ss cultured for 7 days in (A)
nonosteogenic and (B) osteogenic media. At day 7, the osteogenic U20Ss exhibit no apparent
changes in cell morphology. However, there are areas of calcium deposition within the matrix,
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as indicated in Fig. 2Error! Reference source not found.B. When Fig. 2AB is compared with the
day 14 samples Fig. 2 CD, significant changes in the growth patterns of both cultures are
apparent. The U20Ss cultured in nonosteogenic media for 14 days appear to exhibit the typical
characteristics of a mineralising culture. This is due to there being discrete areas of mineral
deposition present in the monolayer, as indicated in Fig. 2C. At day 14 of the U20Ss cultured in
osteogenic media, Fig. 2D, there are large areas of mineral deposition in the extracellular matrix
and also in the areas surrounding the mineralised regions there is evidence that U20Ss are
actively proliferating. This is due to the U20Ss maintaining a cell monolayer that surrounds the
large mineral deposits present as shown in Fig. 2D.

Fig. 3 AF, shows the phase contrast micrographs of U20Ss in the latter stages of culture in both
nonosteogenic (Fig. 3 A, C and E) and osteogenic media (Fig. 3 B, D and F). In the samples
cultured in nonosteogenic media for 21, 25 and 28 days, respectively, there is evidence of
accelerated mineralisation of the matrix in large areas of the cell monolayer. At the same time
points, the cells cultured in osteogenic media aggressively produced bone nodules, which is a
trait that is not normally associated with U20Ss [24]. The areas of the mineralised matrix,
observed in Fig. 3 (B, D and F), appear to be substantially more compact than what is commonly
observed with other similar cell types, and the areas are interconnected with a dense middle
region and dense elongated bridges that are forming the gaps. In comparison with Fig. 2D, there
is also evidence of active proliferation of the U20Ss, as indicated by the black arrow.

To quantify the extent of mineralisation of HOBs and U20Ss, alizarin red staining was
performed on both cell types cultured in both nonosteogenic and osteogenic conditions for 7, 14,
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21 and 28 days using phase contrast microscopy. No appreciable changes were observed in the
nonosteogenic cell cultures over the 28 day culture period. However, this was expected due to
the lack of change in cell morphology over the same culture period.

In work previously

published, Gentleman et al. observed nodule formation from primary osteoblasts which occurred
in discrete patches throughout culture [26]. This is reflected in the alizarin red staining of HOBs
after 28 days in culture, as shown in Fig. 4 AD. The osteogenic cell cultures underwent a
differing growth pattern over the 28 day culture period, as expected due to the morphological
changes observed. HOBs culture for up to 28 days in osteogenic media revealed positive
staining for calcium deposition, which increased steadily through each 7 day interval and at day
28, discrete patches of mineral deposits are evident (Fig. 4 AD).

Conversely, throughout the 28 day culture period, the nonosteogenic U20S samples exhibited a
growth pattern that is typical of that observed during mineralisation (Supplementary Figure 2 A
D). Generally, there are small areas present in the monolayer that show signs of mineralisation
of the matrix, which are indicated by the positive alizarin red staining. The osteogenic cell
culture underwent a similar growth pattern. U20Ss cultured for up to 28 days in osteogenic
media revealed significant positive alizarin red staining for calcium deposition, which increases
rapidly through each 7 day interval up to day 28 (Fig. 5 AD). At this time point, large dense
areas of mineral deposits are evident, as shown in Fig. 5D.

Quantification of alizarin red staining was performed by an alizarin red colorimetric assay using
the cetylpyridinium chloride extraction method. Cells were cultured for the full 28 day culture
period, with samples taken at 7 day intervals. Supplementary Figure 3 shows the quantification
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of both nonosteogenic and osteogenic HOBs and U20Ss cultured for up to 28 days. An increase
in alizarin red staining of HOBs cultured in nonosteogenic media is observed between days 7
14, and in the osteogenic samples as cell proliferation decreases and differentiation increases
during days 2128, the alizarin red staining increased substantially. Supplementary Figure 3 also
shows that alizarin red staining of U20Ss cultured in nonosteogenic media increases
significantly throughout the 28 culture period. The nonosteogenic U20Ss produced a maximum
alizarin red staining at day 28, represented by a value of 0.56, and the minimum was at day 7
with a value of 0.15. In comparison to the results obtained for the nonosteogenic U20Ss, the
alizarin red staining of the osteogenic samples increased as the time in culture increased. The
lowest amount of alizarin red staining was measured at day 7 with a value of 0.33. A statistical
increase was observed at day 28 of culture with a value of 0.93. Based on the changes observed
in the growth pattern during the 28 day period, it was expected that alizarin red staining would be
significantly higher in the osteogenic cultures. However, the nonosteogenic U20Ss had positive
alizarin red staining at higher levels at day 21 that plateaued between days 2128. Despite
having lower levels of alizarin red staining at day 28 in nonosteogenic culture, due to the
observations made in cell morphology, these results follow the expected pattern and highlight
that there is extensive mineralisation in the U20S cultures.

Single cell characterisation of human primary osteoblasts and U20S osteoblastlike cells
The averaged preprocessed Raman spectra of a single HOB cell and U20S cell are shown in Fig.
6 (AB) and are composed of peaks that are representative of all biomolecules present in cells.
The Raman spectra of both cell types are represented as protein/lipid dominated signatures with
prominent protein bands at 1665 cm1 (amide I) and 1248 cm1 (amide III) and strong peaks that
13

are indicative of lipids at Raman frequencies of 720 cm1 (CN stretching), 985 cm1 and 1319 cm
1

(CH bending) and 1448 cm1 (CH deformation). There are also well pronounced bands that

correspond to the OPO backbone stretch (788 cm1) and, specifically in the U20Ss, the peaks at
826 cm1 and 857 cm1, that represent tyrosine ring breathing and OPO asymmetric stretching,
dominate the 800900 cm1 spectral region. The peaks in the region of 750900 cm1 are all
indicative of the nucleic acid component of a cell and Fig. 6B shows that, in U20Ss, the bands in
this region are of a higher intensity than those of HOBs, shown in Fig. 6A.

Raman assessment of the osteoinductive potential of human primary osteoblasts and U20S
osteoblastlike cells
After 28 days in culture, dramatic morphological differences were observed in both cell types.
In HOBs there were very discrete areas of mineralisation and bone nodule formation.
Conversely, in the U20Ss there were large areas of dense mineralised structures.

These

differences are not reflected in the Raman signal obtained from both cell types, as shown in Fig.
7 (AB).

The time in culture has had little to no effect on the Raman spectra obtained at this

time point. Both cell types exhibit a Raman signal dominated by peaks that are characteristic of
bone material, namely those found at ~960 cm1, 1030 cm1 and 1070 cm1. The HOBs and
U20Ss follow the same trend, showing little fluctuation in the results from 28 days, except for a
slight shift in the phosphate peak, where in the case of HOBs this peak is at 960.4 cm1 and in
U20Ss it is recorded at 962.4 cm1. This indicates a small change in mineral species of the
mineral produced by the HOBs between days 21 and 28. However, for HOB samples it is
evident that there is a decrease in the CH2 Wag (1445 cm1) and amide I band (15951720 cm1),
which both relate to lipids and proteins respectively.
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To confirm the presence of phenotypic markers of osteoblast cells, immunocytochemistry was
performed on both cell types after 28 days in culture with nonosteogenic and osteogenic media.
Samples were labelled with antibodies to osteopontin (OPN), osteocalcin (OCN) and alkaline
phosphatase (ALP). Supplementary Figure 4 (AF) shows localisation of OPN, OCN and ALP
in HOBs cultured for 28 days in (AC) nonosteogenic media and (DF) osteogenic media.
Supplementary Figure 5 (AF) shows localisation of OPN, OCN and ALP in U20Ss cultured in
(AC) nonosteogenic media and (DF) osteogenic media for 28 days. The characterisation of
osteogenic cells is often achieved by examining the expression of OPN, OCN and ALP, which
can differ with the stage of differentiation. ALP is usually expressed at higher levels at the
earlier stages of culture; OPN and OCN are both mid to end stage markers of mineralisation.
When comparing Supplementary Figure 4 (AC) with (DF) and Supplementary Figure 5 (AC)
with (DF), it is evident that there is a higher degree of positive staining in the osteogenic
samples when compared with the nonosteogenic samples. These proteins are found only in
bone tissue and, as such, this indicates that an extracellular matrix has been produced by the
HOBs and U20Ss and over time mineralisation occurred. In the U20S samples cultured in non
osteogenic media (Supplementary Figure 5 (AC)), there is some evidence of staining of the
bone specific proteins, and this can be correlated with the cell morphology findings and the
alizarin red results.

The osteoinductive ability of the U20S osteoblastlike cell line described could be a consequence
of the addition of osteogenic supplements in the culture medium. As a result of these conditions,
the osteoinductive capability of U20Ss was assessed when cultured in normal basal culture
medium for 28 days. With regards to U20S osteoblastlike cells, the growth pattern changed
over the 28 day period when cultured in nonosteogenic media. The cells maintained their
15

cuboidal osteoblastlike morphology, and there was evidence of calcium deposition in the
extracellular matrix. Therefore Raman measurements were acquired at this time point, as shown
in Fig. 8. At 7, 14, and 21 days of nonosteogenic culture, the Raman signal was similar to the
control spectra (Fig. 6B). However, at day 28 of nonosteogenic culture, the Raman spectrum
resembles that of the early stages of the mineralising culture. The spectrum contains peaks that
are characteristic of a proteinaceous extracellular matrix with Raman bands at 12461269 cm1
(amide III) and 15951720 cm1 (amide I). The peaks at 788 cm1, 826 cm1 and 857 cm1 that are
indicative of nucleic acids are also prominent in the spectra. The main interesting feature
observed in Fig. 8, is the addition of the peak (962.9 cm1) that highlights the presence of a
hydroxyapatite bonelike mineral in the sample.

Based on these measurements, it can be argued that the structures formed by U20Ss are
representative of a bonelike material and that these mineral deposits were produced early in the
culture. This is illustrated by the presence of the PO symmetric stretch found at 960 cm1,
indicative of the inclusion of hydroxyapatite in the extracellular matrix. It is noteworthy that, to
the authors’ knowledge, there is little published literature to suggest that U20S osteoblastlike
cells produce mineralised nodules with such aggressiveness and density. The results obtained for
U20Ss can be compared to another osteosarcoma derived cell lines, namely SaOS2. Therefore
the production of mineralised tissue could simply be due to the high proliferation rate of the
U20S cell type [24].
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Univariate Peak Analysis
There are many similarities in the Raman spectra obtained from HOBs and U20Ss at day 28.
However small changes in the frequency and peak position of the peaks that are characteristic of
bone were observed, these were examined using univariate peak analysis. This was performed at
7, 14, 21 and 28 days, in an attempt to determine the mineraltomatrix ratio and carbonateto
phosphate ratio of the bonelike material produced by both cell types and to provide a
comparative analysis of these properties, as shown in Table 1 [2628].

In order to calculate the mineraltomatrix ratio, the intensity of the PO43 phosphate symmetric
stretch was used as the metric of mineral content and the hydroxyproline peak at ~850 cm1 was
used as a measure of the matrix content [2628]. Carbonatetophosphate ratios were calculated
according to the methods employed by Gentleman et al [26] and Morris et al [29] , based on the
band intensity of the CO32 in plane vibrations at 1070 cm1, and the intensity of the baseline
corrected PO43 phosphate symmetric stretch at 960 cm1. Although it has been demonstrated that
the overlap between carbonate n 1 and phosphate n3 bands at ~1071cm1 makes it difficult to
distinguish between these bands at low carbonate levels (~0.3%), at higher carbonate levels (1
10%), the ratio of the 1071 cm1 to 960 cm1 peak areas were seen to be well correlated with the
carbonate content [30]. Both ratios were calculated from an average of three band intensities and
a global average was obtained [26, 3133].

The mineraltomatrix ratio measures the amount of mineral in the protein matrix and the
carbonatetophosphate ratio measures the substitution of carbonate into the apatite lattice. The
calculated mineraltomatrix and carbonatetophosphate ratios for primary osteoblasts are
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shown in Table 1. A linear trend is observed throughout the full 28 day culture period for both
the mineraltomatrix and carbonatetophosphate ratios. Hence, as the culture time is increased,
the mineraltomatrix ratio and carbonatetophosphate ratio also increased. From the univariate
analysis, it is demonstrated that the mineraltomatrix and carbonatetophosphate ratios for both
cell types show significant differences. In the case of the primary osteoblasts, the mineralto
matrix ratio increased with culture time, a trait that has been associated with the differentiation of
stem cells into osteoblasts [27, 34] and mineralising calvaria osteoblasts [28, 31].

The

carbonatetophosphate ratios show a ratio at day 7 that increases significantly through culture
time. This highlights that carbonate substitution begins to occur at the earliest stages of culture.
Further to this, the values reported here are similar to those calculated for hMSCs [34] and they
further affirm that carbonate substitution occurs most rapidly between day 14 and 21.
Comparatively, the mineraltomatrix ratio increased 2 fold with culture time, and also reached
values that are similar to those reported in previous work [34]. This confirms that there is
mineral present in the protein matrix as expected. Based on this, it can be said that the mineral
content of the bone tissue at the later culture time is higher and that the deposition of mineral into
the apatite lattice occurs most rapidly during days 21 and 28.

The calculated mineraltomatrix and carbonatetophosphate ratios for U20S osteoblastlike
cells are also shown in Table 1. Notably, while U20Ss follow the same linear pattern of the
carbonatetophosphate and mineraltomatrix ratios observed for the primary cell line,
substantial differences in the calculated values at the same time points are demonstrated. The
carbonatetophosphate ratios increase with culture time and they reach values that are
significantly higher than the primary osteoblasts, indicating that more carbonate has been
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substituted into the apatite lattice. These results are interesting, as the values are significantly
higher than any values reported for the carbonatetophosphate ratios of mineralising cultures.
The carbonatetophosphate ratios may not be in accordance with findings reported by various
research groups [26, 28, 31, 34]. However, the ratio is similar to the carbonatetophosphate
ratio of native bone that was found to have a value of 3.84 ± 0.03. The mineraltomatrix ratios
calculated for U20Ss were also significantly different when compared with the primary
osteoblasts. The maximum ratio after 28 days in culture is 4.51 ± 0.18, whereas the ratio of the
primary osteoblasts at the same time point is 32.4 ± 8.4. This was not expected after the positive
similarity of the carbonatetophosphate ratios to native bone and thus it illustrates that a low
amount of mineral has been deposited in the protein matrix in the case of the osteoblastlike
U20S cells.

Bone quality can be assessed using univariate peak analysis and in particular, the PO43
symmetric band, which is the most intense Raman peak present in the signal from bone tissue,
can be used to investigate bone crystallinity. A major aspect when characterising bone material
is resolving changes in the phosphate band in terms of both frequency and peak position. Bone
mineral crystallinity can be calculated from the full width half maximum (FWHM) of the PO43
symmetric band, whereby the lower the FWHM the higher the crystallinity of the material [34] .
The results reported on the primary osteoblast cells used in this study are consistent with those
reported in the literature from various research groups [26, 35, 36]. This is specifically regarding
the ability of the primary osteoblasts to produce bone nodules in small mineralised areas in the
culture. However, the results obtained from U20S osteoblastlike cells are interesting to say the
least. This is due to the contradictory findings detailed by Anderson et al., Raval et al. and Dass
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et al. who reported that osteoblastlike U20Ss have no osteoinductive ability as they consistently
failed to support the formation of mineralised tissue [2224]. On the contrary, in this study it is
demonstrated that U20Ss do in fact produce mineralised bone tissue, and they do so very
aggressively and in dense multilayered regions of the cell culture. This is in accordance with
studies performed by Hunt et al. [37] who reported that U20Ss expressed higher levels of bone
growth and morphogenic factors than other osteosarcoma cell lines that are well characterised as
being osteoinductive [37].

Based on the findings obtained from the univariate peak analysis, it is suggested that the primary
osteoblasts and osteoblastlike cells did successfully support the formation of mineralised
nodules that are significantly different in composition.

As such, the crystallinity of the

mineralised nodules is determined using the FWHM of the PO symmetric stretch at ~960 cm1 as
shown in Table 2. Based on this, the primary osteoblasts formed a highly crystalline bone
material with the highest degree of crystallinity observed at day 14 with a value of 27.11 ± 5.93.
An interesting point is that the crystallinity of the older more mature bone (day 28) is higher than
the newly formed bone (day 21). This finding could also be due to poorly organised apatite
mineral that occurs during active bone remodelling. The findings reported here are consistent
with those from a study by Farlay et al. who also found that older bone had a higher crystallinity
that new bone tissue [38]. The crystallinity of the bone material reported here is significantly
higher when compared to hMSCs which are from the same origin [34]. This suggests that the
primary osteoblasts produce an apatite mineral that is highly organised, although less so relative
to the crystallinity found in the bone material produced by U20Ss. The mineral produced by
U20Ss is significantly more crystalline when compared to the primary osteoblasts. The highest
degree of crystallinity of U20Ss is observed at day 7 with a value of 14.74 ± 1.64. This was not
20

maintained over longer periods and the crystallinity reached a plateau between days 14 and 28.
Nevertheless, it is suggested that U20Ss still produced a bone material that was significantly
more crystalline than the bone material produced by primary osteoblasts. Another key finding, is
that the crystallinity of the U20S bone material can be compared with that of native bone which
was found to have a FWHM of 19.17 ± 5.13 [34]. The results may indicate that the U20S
osteosarcoma cell line is not a good model for human osteoblasts, unless one defines a good
model as any cell that makes some apatitelike mineral deposited in/on collagen, with measured
bone quality markers that are similar to native bone. Nevertheless, U20Ss may have potential to
serve as a model for evaluating and understanding composition differences between normal bone
and osteoblastic lesions sometimes found when prostate cancer metastasizes to bone [30].

Principal Component Analysis
The results obtained from univariate peak analysis highlighted differences in the composition of
the bone material produced over a 28 day period. Principal component analysis (PCA) was
performed on the Raman spectra obtained from HOBs and U20Ss cultured in osteogenic media
in order to highlight the similarities and/or differences in the data set.

PCA shows the maximum variance within a data set which is then represented by a scatter plot.
The 3D plot comparing the different culture time points for the osteogenic HOBs is displayed in
Fig. 9A. The 3D scores plot shows evidence of significant separation between the 7 day
intervals and subsequently the scores for these cultures times are compactly clustered. PC1, PC2
and PC3 represent 86%, 8% and 2% of the variance of the data set, respectively, although group
separation appears to be primarily due to PC2. The loading of PC1 demonstrates the separation
between day 14 and day 28. This loading is predominantly composed of a sharp peak at ~960
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cm1. Major similarities are observed between the loading of PC1 and the spectra of bone tissue,
specifically in the 9001000 cm1 spectral range, highlighting the contribution of the mineral
species present during the recording of the Raman measurements. The loading of PC2 is a
combination of various peaks with different intensities and it is responsible for discriminating
between the culture period of the day 14 and days 2128. It accounts for 8% of the variance of
the total data set and the loading plot is dominated by spectral features that correspond to the
lipid and protein signatures at 1450 cm1 and 1665 cm1, respectively. From PC2, it can be seen
that there is a negative peak at 960 cm1 that represents the phosphate mode and a positive band
at 1450 cm1 that relates to the CH2 Wag. PC3 represents only 2% of the variance, and as such it
provides evidence of slight intragroup variability in day 14 samples, due to the variation in the
mineral species present at that time point.

As highlighted previously, the use of an osteoblastlike cell line as a model for primary
osteoblasts specifically with regards to the osteoinductive ability is not fully understood. U20Ss
were cultured for a 28 day period in osteogenic media and data preprocessing was performed, as
was the case for the HOBs.

The 3D plot acquired from the U20Ss after PCA and the

corresponding loading plots are displayed in Fig. 10AB, respectively.

U20Ss demonstrated a different pattern in the 3D scores plot. The 3D plot shows that the results
obtained from the PCA of the Raman spectra at day 714 of culture exhibit few distinguishing
differences between the spectra from the two time points as the two groups are overlapping.
Once again, the measurements taken at day 21 and day 28 are consistent with those obtained
from the HOBs in that a clear separation is observed at days 21 and 28. PC1 represents 64% of
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the total variance and this is due to positive peaks in the areas that represent both proteins and
lipids, including in the 12461269 cm1, 13191340 cm1, 1445 cm1, 15201720 cm1 spectral
regions and to the positive loading at ~960 cm1 that corresponds to the phosphate symmetric
stretch. PC2 demonstrates the separation between day 21 and day 28 and PC3 represents the
separation between day 21 and the combined groups of days 7, 14 and 28. PC2 accounts for
19% of the explained variance and with regards to the loading plot it is related to the positive
peak representing the mineral species and the negative peaks corresponding to proteins/lipids.
PC3 represents 6% of the variance and is again related to the mineral species in the Raman
spectra. This indicates that due to the positive loadings in PC1 that reflect proteins/lipids, PC1
causes separation between days 714 from 2128 and PC2 causes separation between days 2128
due to the positive loading representing the mineral species. The loadings of the PCs all contain
a phosphate symmetric stretch at 960 cm1, whilst also containing peaks in the 1400 cm1 and
1600 cm1 spectral region.

The scores and loadings for U20Ss highlight the significant

difference in the bone mineral formed at days 21 and 28. This further affirms the differences
found in the crystallinity of these time points. Overall, PCA shows good separation between the
bone mineral formed at the various time points by both cell types. While PCA does not provide
additional analytical information, it confirms that there are differences in the composition of the
bone material formed by both cell types. Factor analysis was not used in order to determine the
type of mineral formed by both cell types. However, peak fitting was performed and it is note
worthy that the type of mineral formed by the primary cells can be described as a Btype
carbonatesubstituted apatite and a crystalline nonsubstituted hydroxyapatite, respectively. It
was presumed that a carbonatesubstituted apatite would be the main type of mineral found, in
accordance with the high carbonatetophosphates ratios calculated for U20Ss. However, there is
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another mineral type produced by U20Ss, which corresponds to a crystalline nonsubstituted
apatite [28, 31, 32, 34]. The types of mineral found here are in good agreement with those
observed by Stewart et al., and while all of them are markers and precursors of hydroxyapatite,
the fact that there are different mineral species indicates the variability of the bone material
produced by these cell types when cultured under the same conditions for the same period of
time [32].

Conclusion
When considering the use of cell lines and in particular osteosarcoma derived cell lines as an
alternative to primary cells, there are many issues that need to be addressed. On one hand,
osteosarcoma derived cells rapidly proliferate and, because they are immortalized, they maintain
their phenotype. On the other hand, primary osteoblast cells are challenging to culture and with
longer culture times they may become phenotypically unstable [10].

However, the major

shortcomings of the osteosarcoma cell line are 1) that it is derived from a bone tumor that is
consistently known to have a very aggressive growth pattern and 2) it may not be a true
representation of human primary cells of the same origin.

In this regard, both cell types

produced similar patterns in their Raman signal, although one significant difference was
observed. Spectral analysis of the osteosarcoma cells showed an increased concentration of
nucleic acids and lower concentration of proteins in contrast to the human primary osteoblasts
which showed the opposite.

The nonosteoinductive ability of osteosarcoma derived U20Ss is controversial to say the least
and as a consequence it has been examined and compared with human primary osteoblasts in this
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study. In order to do this, various biological, univariate, multivariate techniques were employed
in parallel with Raman spectroscopy to provide a comprehensive comparison of the cell types.

Primary osteoblasts produced a bone mineral in discrete areas of the osteogenic culture. This
began from day 7 and increased throughout the 28 day culture period, while all other parameters
remained the same throughout. This cell type is commonly used to investigate the capability to
produce mineralised nodules. However, in terms of culture methods they are not straight
forward to expand in vitro. U20S osteoblastlike cells, which are the proposed alternative, also
produced a bone material in the osteogenic culture environment over the 28 day period. U20Ss
also produced mineralised nodules when in a nonosteogenic environment. The mineralised
tissue produced by primary cells is more commonly compared with native bone, but in this case
while the material is similar to that formed by differentiated hMSCs [34], based on these findings
it can be said that it is less comparable to native bone. Here it has been shown that the
mineralised structures formed by the osteoblastlike U20Ss has similar attributes to native bone,
i.e. carbonatetophosphate ratio, mineraltomatrix ratio and crystallinity. This observation is
quite surprising considering not only the origin of these cells but also the crucial fact that they
have been consistently reported to have no osteoinductive ability. To the best of the author’s
knowledge, this is the first time to date that the bonelike material produced by U20Ss has been
closely analysed by Raman spectroscopy and univariate analysis in an attempt to give an overall
understanding using the properties that are commonly employed to determine bone quality.
Although the results may indicate that the U20S osteosarcoma cell is not a good model for
human osteoblasts, they may have potential to serve as a model for composition differences
between normal bone and osteoblastic lesions.
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Table 1: Carbonatetophosphate ratios and mineraltomatrix ratios as determined by univariate
analysis carried out by curve fitting Raman spectra of HOBs and U20Ss cultured for 728 days.
For each group spectra were recorded from cells in triplicate. Statistically significant difference
between Sample X and † day 7, ‡ day 14, ₣ day 21 and § day 28.

Carbonate‐to‐phosphate
ratio

Mineral‐to‐matrix ratio

HOBs
1.01 ± 0.21

U20Ss
₣§‡

7.56 ± 4.79

₣§†

14.52 ± 6.24
32.39 ± 8.41

‡†

‡†

1.09 ± 0.91

₣§

2.55 ± 0.05
3.40 ± 0.09
4.51 ± 0.18

₣

HOBs

U20Ss

‐

1.16 ± 1.02

0.21 ± 0.06

§†

₣‡†

0.51 ± 0.34
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₣§

§‡

0.67 ± 0.03

‡

1.81 ± 1.01

₣§

2.47 ± 1.91
3.36 ± 1.80

§

‡

₣‡†

Table 2: Phosphate peak analysis and mineral crystallinity as determined by univariate analysis
carried out by curve fitting Raman spectra of HOBs and U20Ss cultured for 728 days in
osteogenic media. For each group spectra were recorded from cells in triplicate and n represents
the number of spectra recorded.

Phosphate Peak
‐1

‐1

Frequency (cm )

FWHM (cm )

HOBs

U20Ss

HOBs

U20Ss

Day 7 (n=13)

‐

960.77 ± 0.00

‐

14.74 ± 1.64

Day 14 ( n=13)

958.85 ± 3.36

962.86 ± 0.94

27.11 ± 5.93

20.80 ± 2.14

Day 21 (n=13)

961.59 ± 0.04

962.38 ± 0.07

53.82 ± 1.66

23.55 ± 4.97

Day 28 (n=13)

960.42 ± 0.82

962.42 ± 0.07

32.14 ± 12.50

22.39 ± 9.45
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Figure Legends

Figure 1: Phase contrast micrographs of HOBs cultured for (A) 28 days in nonosteogenic
media, (B) 7 days, (C), 14 days, (D) 21 days and (E) 28 days in osteogenic media. The scale bar
represents 50 μm.
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Figure 2: Phase contrast micrographs of U20Ss cultured in nonosteogenic media for (A) 7 days,
(C) 14 days and U20Ss cultured in osteogenic media for (B) 7 days and (D) 14 days. The scale
bar represents 50 μm.
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Figure 3: Phase contrast micrographs of U20Ss cultured in nonosteogenic media for (A) 21
days, (C) 25 days, (E) 28 days and U20Ss cultured in osteogenic media for (B) 21 days, (D) 25
days and (F) 28 days. The scale bar represents (AF) 50 μm.
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Figure 4: Alizarin red staining of HOBs cultured in osteogenic media for (A) 7 days, (B) 14
days, (C) 21 days and (D) 28 days. The scale bar represents (AD) 50 μm.
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Figure 5: Alizarin red staining of U20Ss cultured in osteogenic media for (A) 7 days, (B) 14
days, (C) 21 days and (D) 28 days. The scale bar represents (AD) 50 μm.
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Figure 6: Raman spectra of (A) HOBs cultured for 48 hours in nonosteogenic media and (B)
U20Ss cultured for 48 hours in nonosteogenic media.
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Figure 7: Raman spectra of (A) HOBs and (B) U20Ss cultured in osteogenic media for 28 days.
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Figure 8: Raman spectra of U20Ss cultured for 28 days in nonosteogenic media.
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Figure 9: (A) Scatter plot of the 3 first principal components after PCA was carried out on the
Raman spectra recorded from HOBs grown in osteogenic media and (B) shows a plot of the
loadings that correspond to the 3 first principal components used for Figure 9 (A).
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Figure 10: (A) Scatter plot of the 3 first principal components after PCA was carried out on the
Raman spectra recorded from U20Ss grown in osteogenic media and (B) shows a plot of the
loadings that correspond to the 3 first principal components used for Figure 10 (A).
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Supplementary Figures

Supplementary Figure 1: Phase contrast micrographs of (A) HOBs and (C) U20Ss cultured for
48 h in nonosteogenic media and immunofluorescent labelling of (B) HOBs and (D) U20Ss
cultured in nonosteogenic media. The scale bar represents (B) 20 μm and (D) 10 μm.

39

Supplementary Figure 2: Alizarin red staining of U20Ss cultured in nonosteogenic media for
(A) 7 days, (B) 14 days, (C) 21 days and (D) 28 days.
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Supplementary Figure 3: Graph showing the quantification of alizarin red staining for HOBs
and U20Ss cultured for 28 days in both nonosteogenic and osteogenic media.
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Supplementary Figure 4: Immunocytochemical localisation of OPN, OCN and ALP of HOBs
cultured in nonosteogenic media (AC) and osteogenic media (DF) for 28 days. The scale bar
represents 50 μm.
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Supplementary Figure 5: Immunocytochemical localisation of OPN, OCN and ALP of U20Ss
cultured for 28 days in nonosteogenic media (AC) and osteogenic media (DF). The scale bar
represents 50 μm.
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